Category
Oxford Silk Phage Technologies Ltd. (OSPT) is an Oxford-based life-science company developing a novel antibacterial material integrating bacteriophages, to prevent surgical site infections and reduce the need for antibiotics.
OSPT’s proprietary processes enable the integration of highly infective cocktails of bacteriophages in its feedstock material. Medical devices and implants produced using the feedstock material will reduce the risk of contamination by the most prevalent bacteria in the various surgical sectors.